Arbonne Appoints New CEO
Arbonne International LLC announces Katherine "Kay" Napier has joined the company as its new chief executive officer. Napier will lead all key facets of Arbonne's global business while reinvigorating the company's focus on its core principles, established almost 30 years ago: To create products that are pure, safe and beneficial. Arbonne creates opportunities for people seeking meaningful financial, social, cultural and intellectual rewards; and encourages all members of the organization to contribute locally, nationally and internationally to the improvement of our ecological, social and cultural environment.
Napier most recently held the position of senior vice president, Marketing for McDonald's. While at McDonald's, she led the reinvention of its Happy Meal business, directed the development of its "go active" product and marketing initiatives, and deepened the brand's connection with women and families through the roll-out of information about healthier living and the development of healthier product choices.
Prior to McDonald's, Napier retired from Procter & Gamble as vice president, North America Pharmaceuticals and Corporate Women's Health and Vitality, culminating a 23 year career at the consumer products leader. Among her many accomplishments, Napier spearheaded the development and marketing of Procter & Gamble's Actonel osteoporosis drug, which transformed the company's pharmaceutical business.
Napier most recently held the position of senior vice president, Marketing for McDonald's. While at McDonald's, she led the reinvention of its Happy Meal business, directed the development of its "go active" product and marketing initiatives, and deepened the brand's connection with women and families through the roll-out of information about healthier living and the development of healthier product choices.
Prior to McDonald's, Napier retired from Procter & Gamble as vice president, North America Pharmaceuticals and Corporate Women's Health and Vitality, culminating a 23 year career at the consumer products leader. Among her many accomplishments, Napier spearheaded the development and marketing of Procter & Gamble's Actonel osteoporosis drug, which transformed the company's pharmaceutical business.